🇺🇸 FDA
Patent

US 6752996

Use of parapox PP30 protein to modify immune responses to administered antigens

expired A61KA61K2039/53A61K2039/55516

Quick answer

US patent 6752996 (Use of parapox PP30 protein to modify immune responses to administered antigens) held by The Board of Regents of the University of Texas System expires Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 22 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/53, A61K2039/55516, A61K2039/55561, A61K38/162